A. General Description of Advisory Firm Blue Water Life Science Advisors, LP (the “Adviser” or “Blue Water”), is a limited partnership organized under the laws of the State of Delaware. The Adviser was formed on June 3, 2014 as a limited liability company organized under the laws of the State of Delaware, as Blue Water Private Capital LLC. The Adviser’s name was changed on January 11, 2017, to Blue Water Life Science Advisors, LLC. On December 29, 2021, the Adviser converted from a Delaware limited liability company to a Delaware limited partnership and, in connection with such conversion, changed its name to Blue Water Life Science Advisors, LP. The Adviser’s principal place of business is in Larkspur, California. Nathaniel (“Nate”) T. Cornell is the principal owner of Blue Water. The Adviser’s general partner is Blue Water Life Science Advisors GP, LLC, a limited liability company organized under the State of Delaware. The Adviser is a registered investment adviser with the SEC. B. Description of Advisory Services (including any specializations) The Adviser provides investment advisory services on a discretionary basis to its clients, which are pooled investment vehicles (each, a “Fund” and together, the “Clients”). Investors in a Fund are generally “accredited investors” within the meaning of Rule 501(a) under the Securities Act of 1933, as amended (the “Securities Act”), and are generally “qualified purchasers” within the meaning of Section 2(a)(51) under the Investment Company Act of 1940, as amended (the “Investment Company Act”) and “qualified clients” within the meaning of Rule 205-3 under the Advisers Act. Currently, the Funds advised by Blue Water consist

of the following: - Blue Water Life Science Fund, LP (the “Onshore Feeder Fund”), Blue Water Life Science Offshore Fund, Ltd. (the “Offshore Feeder Fund”), and the Blue Water Life Science Master Fund, Ltd. (the “Master Fund”, and together with Onshore Feeder Fund and Offshore Feeder Fund, the “LS Funds”). - Blue Water Special Opportunities, LP, a co-investment vehicle that generally invests opportunistically in securities issued by a limited number of portfolio companies; and - Blue Water Ventures Fund, LP (the “Ventures Fund”). The Adviser mainly invests client assets in life sciences companies with a focus on technology platforms, diagnostics, and devices. Clients may opportunistically invest in emerging pharmaceutical companies, establish short sale positions, and deploy portfolio hedges. Notwithstanding the foregoing, the Adviser has the flexibility to make a broad range of investments and to act opportunistically on behalf of its Clients. C. Availability of Tailored Services for Individual Clients Blue Water’s advisory services are provided to its Clients pursuant to the terms of each Client’s applicable offering documents. The advisory services a Fund receives are tailored to meet the specified investment objectives and strategies as set forth in the Fund’s offering documents. Investors generally cannot impose additional investment guidelines, restrictions, or other requirements on such Fund. D. Wrap Fees The Adviser currently does not participate in any wrap fee programs. E. Client Assets Under Management As of December 31st, 2023, the Adviser manages approximately $160,225,734 of regulatory assets on a discretionary basis.